Adaptimmune Therapeutics PLC - ADR (ADAP) Reaches $6.98 After 9.00% Down Move; Westport Innovations (WPRT)’s Sentiment Is 1.09

October 23, 2017 - By Kurt Siggers

Westport Fuel Systems Inc, formerly Westport Innovations Inc, is a Canada well-known provider of low-emission engine and fuel system technologies utilizing gaseous fuels. The company has market cap of $458.78 million. It operates through the Westport Operations segment. It currently has negative earnings. The Westport Operations segment designs, makes and sells compressed natural gas, liquefied natural gas, and liquefied petroleum gas components and systems to original equipment manufacturers and to aftermarket customers.

The stock of Adaptimmune Therapeutics PLC - ADR (NASDAQ:ADAP) is a huge mover today! About 149,427 shares traded. Adaptimmune Therapeutics PLC - ADR (NASDAQ:ADAP) has declined 43.56% since October 23, 2016 and is downtrending. It has underperformed by 60.26% the S&P500.The move comes after 7 months negative chart setup for the $652.76 million company. It was reported on Oct, 23 by We have $6.35 PT which if reached, will make NASDAQ:ADAP worth $58.75 million less.

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The company has market cap of $652.76 million. The Firm is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor T-cell platform. It currently has negative earnings. The Firm has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR, and produce TCR therapeutic candidates for administration to patients.

Analysts await Adaptimmune Therapeutics PLC - ADR (NASDAQ:ADAP) to report earnings on November, 9. They expect $-0.27 earnings per share, down 12.50% or $0.03 from last year’s $-0.24 per share. After $-0.24 actual earnings per share reported by Adaptimmune Therapeutics PLC - ADR for the previous quarter, Wall Street now forecasts 12.50% negative EPS growth.

Among 4 analysts covering Adaptimmune Therapeutics PLC (NASDAQ:ADAP), 2 have Buy rating, 1 Sell and 1 Hold. Therefore 50% are positive. Adaptimmune Therapeutics PLC had 4 analyst reports since February 25, 2016 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, February 25 by Citigroup. The firm has “Buy” rating given on Tuesday, June 6 by Cowen & Co. The stock of Adaptimmune Therapeutics PLC - ADR (NASDAQ:ADAP) earned “Underperform” rating by Bank of America on Monday, October 24.

Grace & White Inc Ny holds 0.83% of its portfolio in Westport Fuel Systems Inc (USA) for 1.62 million shares. Paradigm Capital Management Inc Ny owns 500,600 shares or 0.11% of their US portfolio. Moreover, Norris Perne & French Llp Mi has 0.07% invested in the company for 168,213 shares. The Maryland-based Marathon Capital Management has invested 0.04% in the stock. Oppenheimer & Close Llc, a New York-based fund reported 15,000 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By :